Executive Director & Founder Norman J. Scherzer announced his retirement today after 20+ years of leading the Life Raft Group; former VP of Program Services Sara Rothschild has been appointed to Executive Director position supported by Deputy Executive Director Laura Occhiuzzi, and our experienced LRG staff.
Erawati Bawle shares her insights on her husband's journey with GIST and reflects on the quality of medical care he received and a clinician's responsibility for their patients with the hope that it will give others clarity for their journey.
The LRG welcomes three new members to its Board of Directors: Pat Bonda-Swenson, Santy DiSabatino and Bill Borwegen.
Each member has a unique story, but all reflect the intrinsic courage of one facing the challenge of GIST. It's Time to Tell the Stories! Thanatcha Cholpradit shares her story.
International access to cancer treatment can be challenging. Access to effective treatment in a time of war provides a an even more daunting challenge.
Join medical professionals and the patient advocacy community on Tuesday, April 26, 2022 for a CME conference, “Rare Cancers: Great Unmet Medical Needs” hosted by Columbia University Herbert Irving Comprehensive Cancer Center and the Jed Ian Taxel Foundation for Rare Cancer Research.
The Life Raft Group welcomes new leadership to the our Board of Directors.
This webinar is the Life Raft Group's presentation in honor of Rare Disease Day. Rare disease day is an observance held on the last day of February to raise awareness for rare diseases and to help improve access to treatment and medical care.
The Life Raft Group welcomes our newest Medical Advisory Board (MAB) member Dr. Neeta Somaiah of The University of Texas MD Anderson Cancer Center.
NCCN’s Dr. Crystal Denlinger and Dottie Shead reviewed general principles of appropriate survivorship care and how to access and understand patient guidelines related to survivorship care.
